Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Apr;13(2):137-45.
doi: 10.1097/00008390-200304000-00005.

Increased expression of apoptotic markers in melanoma

Affiliations

Increased expression of apoptotic markers in melanoma

Michael Slater et al. Melanoma Res. 2003 Apr.

Abstract

Extensive labelling for the apoptotic markers calcium channel receptor P2X(7) and caspase-3 and telomerase activity was co-localized at a similar intensity in areas affected by superficial spreading melanoma obtained from 80 patients. Labelling for each of these markers also extended 2 microm from the melanoma into the keratinocyte layer of the adjacent normal epidermis. Conversely, the calcium-regulating receptors P2X(1-3) and P2Y(2) (found in normal but not neoplastic skin) were fully de-expressed within 2 microm of the melanoma but fully expressed beyond that distance. The cell adhesion protein E-cadherin (also only present in normal skin) was progressively de-expressed from a point 2 microm from the melanoma until full de-expression within the lesion. These results show that telomerase-induced proliferation and defensive apoptosis are co-localized and simultaneous processes in melanoma tissue. Melanoma cell proliferation appears to overwhelm the apoptotic defence, perhaps due to the anti-apoptotic effects of telomerase. In addition, keratinocyte regulation of the epidermis and dermis is severely compromised by the loss of E-cadherin and P2X(1-3) and P2Y(2) receptors, resulting in a lesion that is aggressive and malignant.

PubMed Disclaimer

Similar articles

Cited by

  • Promoters with cancer cell-specific activity for melanoma gene therapy.
    Pleshkan VV, Alekseenko IV, Zinovyeva MV, Vinogradova TV, Sverdlov ED. Pleshkan VV, et al. Acta Naturae. 2011 Apr;3(2):13-21. Acta Naturae. 2011. PMID: 22649681 Free PMC article.
  • P2X7 in Cancer: From Molecular Mechanisms to Therapeutics.
    Lara R, Adinolfi E, Harwood CA, Philpott M, Barden JA, Di Virgilio F, McNulty S. Lara R, et al. Front Pharmacol. 2020 Jun 4;11:793. doi: 10.3389/fphar.2020.00793. eCollection 2020. Front Pharmacol. 2020. PMID: 32581786 Free PMC article. Review.
  • Purinergic signalling and cancer.
    Burnstock G, Di Virgilio F. Burnstock G, et al. Purinergic Signal. 2013 Dec;9(4):491-540. doi: 10.1007/s11302-013-9372-5. Purinergic Signal. 2013. PMID: 23797685 Free PMC article. Review.
  • Potential role of P2X7R in esophageal squamous cell carcinoma proliferation.
    Santos AA Jr, Cappellari AR, de Marchi FO, Gehring MP, Zaparte A, Brandão CA, Lopes TG, da Silva VD, Pinto LFR, Savio LEB, Moreira-Souza ACA, Coutinho-Silva R, Paccez JD, Zerbini LF, Morrone FB. Santos AA Jr, et al. Purinergic Signal. 2017 Sep;13(3):279-292. doi: 10.1007/s11302-017-9559-2. Epub 2017 Apr 11. Purinergic Signal. 2017. PMID: 28397110 Free PMC article.
  • The Role of Calcium Signaling in Melanoma.
    Zhang H, Chen Z, Zhang A, Gupte AA, Hamilton DJ. Zhang H, et al. Int J Mol Sci. 2022 Jan 18;23(3):1010. doi: 10.3390/ijms23031010. Int J Mol Sci. 2022. PMID: 35162934 Free PMC article. Review.

MeSH terms